Link to Full Article Cambridge, UK., 9th July 2019: Arecor Ltd (“Arecor” or “the Company”), the specialty pharmaceutical company leveraging its innovative and proprietary formulation technology to develop superior treatments for a range of disease areas, including diabetes, today announces that it has signed a further collaboration with a major global pharmaceutical company. Under this […]
/wp-content/uploads/2018/01/BSM_logo.png00victoria/wp-content/uploads/2018/01/BSM_logo.pngvictoria2019-07-09 04:28:572019-07-12 04:31:47ARECOR SIGNS A NEW FORMULATION EVALUATION AGREEMENT WITH AN EXISTING PARTNER, A MAJOR GLOBAL PHARMACEUTICAL COMPANY
Link to Full Article Innovative regenerative technology using patients’ own skin cells significantly reduced size of wounds caused by diabetic foot ulcers in all patients Valencia, Calif., USA, and Melbourne, Australia, 01 July 2019 — AVITA Medical (ASX: AVH, OTCQX: AVMXY) a global regenerative medicine company, announced today favorable results from an open-label feasibility study […]
/wp-content/uploads/2018/01/BSM_logo.png00victoria/wp-content/uploads/2018/01/BSM_logo.pngvictoria2019-07-01 04:33:102019-07-12 04:44:08RECELL® System Feasibility Study Results for Treatment of Diabetic Foot Ulcers Presented at 11th Annual Congress of the Japanese Society of Limb Salvage & Podiatric Medicine
Artarmon, NSW, Australia – June 28, 2019 – Saluda Medical Pty Limited (“Saluda Medical”) today announced that it has secured $75 million in equity financing from Boston Scientific Corporation (NYSE: BSX) and Redmile Group LLC to fund the final stages of development through commercialization of its Evoke® ECAP-Controlled, Closed-Loop Spinal Cord Stimulation (SCS) System for […]
/wp-content/uploads/2018/01/BSM_logo.png00victoria/wp-content/uploads/2018/01/BSM_logo.pngvictoria2019-06-28 05:20:232019-07-12 05:21:00Saluda Medical Raises $75 Million Equity Financing from Boston Scientific and Redmile Group
Proceeds to fund continued development of Evoke® ECAP-Controlled, Closed-Loop Spinal Cord Stimulation (SCS) System Evoke Trial Validates Level I Evidence Achieved Through First Double-Blind Randomized U.S. Pivotal Study in SCS Proceeds to fund continued development of Evoke® ECAP-Controlled, Closed-Loop Spinal Cord Stimulation (SCS) System Evoke Trial Validates Level I Evidence Achieved Through First Double-Blind Randomized U.S. […]
/wp-content/uploads/2018/01/BSM_logo.png00victoria/wp-content/uploads/2018/01/BSM_logo.pngvictoria2019-06-27 05:21:492019-07-12 05:23:34Saluda Medical Secures Debt Financing From Medtronic
Link to Full Article Executive Summary A new study shows the Personal KinetiGraph wearable monitor can help clinicians identify the Parkinson’s disease patients most likely to benet from device-assisted therapies, including deep brain stimulation. Global Kinetics’ Personal KinetiGraph (PKG) wearable sensor system can identify the best candidates for deviceassisted therapies for Parkinson’s disease, including deep […]
/wp-content/uploads/2018/01/BSM_logo.png00victoria/wp-content/uploads/2018/01/BSM_logo.pngvictoria2019-06-20 05:05:432019-07-12 05:13:06Global Kinetics’ Personal KinetiGraph Identies Parkinson’s Patients Suitable For Deep Brain Stimulation
Link to Full Article A new study shows the Personal KinetiGraph wearable monitor can help clinicians identify the Parkinson’s disease patients most likely to benet from device-assisted therapies, including deep brain stimulation. Global Kinetics’ Personal KinetiGraph (PKG) wearable sensor system can identify the best candidates for deviceassisted therapies for Parkinson’s disease, including deep brain stimulation, […]
/wp-content/uploads/2018/01/BSM_logo.png00victoria/wp-content/uploads/2018/01/BSM_logo.pngvictoria2019-06-19 03:59:312019-06-26 04:11:09Global Kinetics’ Personal KinetiGraph Identies Parkinson’s Patients Suitable For Deep Brain Stimulation
Link to Full Article People with multiple sclerosis (MS) are being sought to take part in a study that aims to investigate the benefits of a robotic walking device. Karen Saunders, a consultant clinical and research neuro-physiotherapist, is the co-investigator on a feasibility trial that is evaluating the use of a balance exercise programme that […]
/wp-content/uploads/2018/01/BSM_logo.png00victoria/wp-content/uploads/2018/01/BSM_logo.pngvictoria2019-06-17 05:16:202019-07-12 05:18:40'Unique' rehabilitation exercise trial seeks participants with MS
Link to Full Article Applications of ADCs are widening and improvements in the manufacturing process meet industry requirements. Charlie Johnson, CEO, ADC Bio06.13.19 The scale of patient demand has fueled an overarching healthcare market need to expand the drug development pipeline to generate more biologics to treat multiple diseases and innovative new biopharmaceuticals to further […]
/wp-content/uploads/2018/01/BSM_logo.png00victoria/wp-content/uploads/2018/01/BSM_logo.pngvictoria2019-06-13 04:27:342019-06-17 04:30:11The ADC Market is Fast Evolving
Link to Full Article Abstracts Showcase Research on Potential Use of RECELL® System in Regenerative Dermatology Valencia, Calif., USA, and Melbourne, Australia, June 12, 2019 —AVITA Medical (ASX: AVH, OTCQX: AVMXY), a regenerative medicine company with a technology platform positioned to address unmet medical needs in therapeutic skin restoration, announces new preliminary RECELL® Autologous Cell […]
/wp-content/uploads/2018/01/BSM_logo.png00victoria/wp-content/uploads/2018/01/BSM_logo.pngvictoria2019-06-12 04:33:222019-06-17 04:39:28AVITA Medical Announces RECELL® System Preliminary Data Focused on Vitiligo and Facial Acne Scars at the 24th Annual World Congress of Dermatology
Link to Full Article Novel screening tool provides first objective assessment for managing referral for deviceassisted therapy (DAT), including deep brain stimulation (DBS) and infusion therapies, and has potential to improve management of Parkinson’s Disease PORTSMOUTH, N.H. and LONDON and MELBOURNE, Australia, June 04, 2019 (GLOBE NEWSWIRE) — Global Kinetics Corporation Ltd. today announced the […]
/wp-content/uploads/2018/01/BSM_logo.png00victoria/wp-content/uploads/2018/01/BSM_logo.pngvictoria2019-06-04 05:01:002019-06-17 05:07:31Data Published in Sensors Supports the Use of Global Kinetics’ Personal KinetiGraph® for Objective Assessment of Parkinson’s Disease Patients Who May Benefit From Device-Assisted Therapies
ARECOR SIGNS A NEW FORMULATION EVALUATION AGREEMENT WITH AN EXISTING PARTNER, A MAJOR GLOBAL PHARMACEUTICAL COMPANY
/in ArecorLink to Full Article Cambridge, UK., 9th July 2019: Arecor Ltd (“Arecor” or “the Company”), the specialty pharmaceutical company leveraging its innovative and proprietary formulation technology to develop superior treatments for a range of disease areas, including diabetes, today announces that it has signed a further collaboration with a major global pharmaceutical company. Under this […]
RECELL® System Feasibility Study Results for Treatment of Diabetic Foot Ulcers Presented at 11th Annual Congress of the Japanese Society of Limb Salvage & Podiatric Medicine
/in Avita MedicalLink to Full Article Innovative regenerative technology using patients’ own skin cells significantly reduced size of wounds caused by diabetic foot ulcers in all patients Valencia, Calif., USA, and Melbourne, Australia, 01 July 2019 — AVITA Medical (ASX: AVH, OTCQX: AVMXY) a global regenerative medicine company, announced today favorable results from an open-label feasibility study […]
Saluda Medical Raises $75 Million Equity Financing from Boston Scientific and Redmile Group
/in Saluda MedicalArtarmon, NSW, Australia – June 28, 2019 – Saluda Medical Pty Limited (“Saluda Medical”) today announced that it has secured $75 million in equity financing from Boston Scientific Corporation (NYSE: BSX) and Redmile Group LLC to fund the final stages of development through commercialization of its Evoke® ECAP-Controlled, Closed-Loop Spinal Cord Stimulation (SCS) System for […]
Saluda Medical Secures Debt Financing From Medtronic
/in Saluda MedicalProceeds to fund continued development of Evoke® ECAP-Controlled, Closed-Loop Spinal Cord Stimulation (SCS) System Evoke Trial Validates Level I Evidence Achieved Through First Double-Blind Randomized U.S. Pivotal Study in SCS Proceeds to fund continued development of Evoke® ECAP-Controlled, Closed-Loop Spinal Cord Stimulation (SCS) System Evoke Trial Validates Level I Evidence Achieved Through First Double-Blind Randomized U.S. […]
Global Kinetics’ Personal KinetiGraph Identies Parkinson’s Patients Suitable For Deep Brain Stimulation
/in GKCLink to Full Article Executive Summary A new study shows the Personal KinetiGraph wearable monitor can help clinicians identify the Parkinson’s disease patients most likely to benet from device-assisted therapies, including deep brain stimulation. Global Kinetics’ Personal KinetiGraph (PKG) wearable sensor system can identify the best candidates for deviceassisted therapies for Parkinson’s disease, including deep […]
Global Kinetics’ Personal KinetiGraph Identies Parkinson’s Patients Suitable For Deep Brain Stimulation
/in GKCLink to Full Article A new study shows the Personal KinetiGraph wearable monitor can help clinicians identify the Parkinson’s disease patients most likely to benet from device-assisted therapies, including deep brain stimulation. Global Kinetics’ Personal KinetiGraph (PKG) wearable sensor system can identify the best candidates for deviceassisted therapies for Parkinson’s disease, including deep brain stimulation, […]
‘Unique’ rehabilitation exercise trial seeks participants with MS
/in Rex BionicsLink to Full Article People with multiple sclerosis (MS) are being sought to take part in a study that aims to investigate the benefits of a robotic walking device. Karen Saunders, a consultant clinical and research neuro-physiotherapist, is the co-investigator on a feasibility trial that is evaluating the use of a balance exercise programme that […]
The ADC Market is Fast Evolving
/in ADC BioLink to Full Article Applications of ADCs are widening and improvements in the manufacturing process meet industry requirements. Charlie Johnson, CEO, ADC Bio06.13.19 The scale of patient demand has fueled an overarching healthcare market need to expand the drug development pipeline to generate more biologics to treat multiple diseases and innovative new biopharmaceuticals to further […]
AVITA Medical Announces RECELL® System Preliminary Data Focused on Vitiligo and Facial Acne Scars at the 24th Annual World Congress of Dermatology
/in Avita MedicalLink to Full Article Abstracts Showcase Research on Potential Use of RECELL® System in Regenerative Dermatology Valencia, Calif., USA, and Melbourne, Australia, June 12, 2019 —AVITA Medical (ASX: AVH, OTCQX: AVMXY), a regenerative medicine company with a technology platform positioned to address unmet medical needs in therapeutic skin restoration, announces new preliminary RECELL® Autologous Cell […]
Data Published in Sensors Supports the Use of Global Kinetics’ Personal KinetiGraph® for Objective Assessment of Parkinson’s Disease Patients Who May Benefit From Device-Assisted Therapies
/in GKCLink to Full Article Novel screening tool provides first objective assessment for managing referral for deviceassisted therapy (DAT), including deep brain stimulation (DBS) and infusion therapies, and has potential to improve management of Parkinson’s Disease PORTSMOUTH, N.H. and LONDON and MELBOURNE, Australia, June 04, 2019 (GLOBE NEWSWIRE) — Global Kinetics Corporation Ltd. today announced the […]